Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors
- PMID: 31744827
- DOI: 10.1136/annrheumdis-2019-216576
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors
Keywords: T cells; cytokines; rheumatoid arthritis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors' by Meyer et al.Ann Rheum Dis. 2021 Dec;80(12):e197. doi: 10.1136/annrheumdis-2019-216598. Epub 2020 Jan 21. Ann Rheum Dis. 2021. PMID: 31964656 No abstract available.
Comment on
-
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.Ann Rheum Dis. 2019 Feb;78(2):209-217. doi: 10.1136/annrheumdis-2018-214229. Epub 2018 Nov 24. Ann Rheum Dis. 2019. PMID: 30472651 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
